Optimization of von Willebrand factor multimer analysis in vertical mini-gel electrophoresis systems: A rapid procedure

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTHOMAZINI, Camila Martos
dc.contributor.authorSOARES, Rosangela de Paula Silva
dc.contributor.authorROCHA, Tania Rubia Flores da
dc.contributor.authorSACHETTO, Ana Teresa Azevedo
dc.contributor.authorSANTORO, Marcelo Larami
dc.date.accessioned2019-03-26T14:42:25Z
dc.date.available2019-03-26T14:42:25Z
dc.date.issued2019
dc.description.abstractVon Willebrand disease (VWD) is a common cause of bleeding worldwide. Analysis of von Willebrand factor (VWF) multimer distribution (VWF:MD) is essential to properly classify and treat different types of VWD, and it is performed using a SDS agarose gel electrophoresis followed by Western blotting, a handmade technique that demands days to be completed and requires skillful execution. Aiming both to facilitate gel production and to shorten the preparation time, we developed an uncomplicated technique to provide agility in the analysis of VWF:MD, so that it can be easily accomplished in the routine practice of hemostasis laboratories. On that account, we used a commercial vertical mini-gel electrophoresis system for SDS-PAGE and a semi-dry transfer system, which allowed us to analyze VWF:MD of various samples in a period shorter than 12 h. This technique differentiated VWF:MD in human and animal plasmas under normal, congenital and acquired (experimental envenomation by Bothrops jararaca snake) conditions. This optimized method is cheap, rapid, reproducible, easy to be performed, and uses electrophoresis and Western blotting systems available in most laboratories. All these advantages encourage hemostasis professionals to use it in their routine practices. In order to facilitate the setup and accomplishment of the whole procedure step by step, videos were appended to the article.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP) [2013/25177-0, 2013/20239-8]
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305245/2015-5]
dc.description.sponsorshipFundacao Butantan
dc.identifier.citationTHROMBOSIS RESEARCH, v.175, p.76-83, 2019
dc.identifier.doi10.1016/j.thromres.2019.01.018
dc.identifier.issn0049-3848
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/31256
dc.language.isoeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTDeng
dc.relation.ispartofThrombosis Research
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright PERGAMON-ELSEVIER SCIENCE LTDeng
dc.subjectADAMTS13eng
dc.subjectBleedingeng
dc.subjectDiagnosiseng
dc.subjectElectrophoresiseng
dc.subjectProteolysiseng
dc.subject.othervonwillebrand-factoreng
dc.subject.othervenom metalloproteinaseseng
dc.subject.othertriplet structureeng
dc.subject.otherdisulfide bondseng
dc.subject.otherglycoprotein-ibeng
dc.subject.otherdiseaseeng
dc.subject.otherplasmaeng
dc.subject.otherclassificationeng
dc.subject.otherdiagnosiseng
dc.subject.otherthrombocytopeniaeng
dc.subject.wosHematologyeng
dc.subject.wosPeripheral Vascular Diseaseeng
dc.titleOptimization of von Willebrand factor multimer analysis in vertical mini-gel electrophoresis systems: A rapid procedureeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus8
hcfmusp.contributor.author-fmusphcCAMILA MARTOS THOMAZINI
hcfmusp.contributor.author-fmusphcROSANGELA DE PAULA SILVA SOARES
hcfmusp.contributor.author-fmusphcTANIA RUBIA FLORES DA ROCHA
hcfmusp.contributor.author-fmusphcANA TERESA AZEVEDO SACHETTO
hcfmusp.contributor.author-fmusphcMARCELO LARAMI SANTORO
hcfmusp.description.beginpage76
hcfmusp.description.endpage83
hcfmusp.description.volume175
hcfmusp.origemWOS
hcfmusp.origem.pubmed30731387
hcfmusp.origem.scopus2-s2.0-85060920911
hcfmusp.origem.wosWOS:000458802600014
hcfmusp.publisher.cityOXFORDeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceBowen DJ, 2007, THROMB HAEMOSTASIS, V97, P1051, DOI 10.1160/TH06-12-0726eng
hcfmusp.relation.referenceBudde U, 2002, SEMIN THROMB HEMOST, V28, P173, DOI 10.1055/s-2002-27820eng
hcfmusp.relation.referenceBudde U, 2015, EXPERT REV HEMATOL, V8, P799, DOI 10.1586/17474086.2015.1060854eng
hcfmusp.relation.referenceCastaman G, 2016, SEMIN THROMB HEMOST, V42, P478, DOI 10.1055/s-0036-1579638eng
hcfmusp.relation.referenceCOUNTS RB, 1978, J CLIN INVEST, V62, P702, DOI 10.1172/JCI109178eng
hcfmusp.relation.referenceDALTON RG, 1988, THROMB RES, V50, P345, DOI 10.1016/0049-3848(88)90237-Xeng
hcfmusp.relation.referenceDONG ZG, 1994, J BIOL CHEM, V269, P6753eng
hcfmusp.relation.referenceFavaloro EJ, 2017, HAEMOPHILIA, V23, pE373, DOI 10.1111/hae.13261eng
hcfmusp.relation.referenceFavaloro EJ, 2016, PATHOLOGY, V48, P303, DOI 10.1016/j.pathol.2016.03.001eng
hcfmusp.relation.referenceFavaloro EJ, 2011, BLOOD COAGUL FIBRIN, V22, P553, DOI 10.1097/MBC.0b013e32834a7e01eng
hcfmusp.relation.referenceFEDERICI AB, 1989, BRIT J HAEMATOL, V73, P93, DOI 10.1111/j.1365-2141.1989.tb00226.xeng
hcfmusp.relation.referenceFederici AB, 2009, BLOOD, V113, P526, DOI 10.1182/blood-2008-04-152280eng
hcfmusp.relation.referenceFischer BE, 1998, BIOCHEM J, V331, P483, DOI 10.1042/bj3310483eng
hcfmusp.relation.referenceFOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129eng
hcfmusp.relation.referenceFRETTO LJ, 1986, J BIOL CHEM, V261, P5679eng
hcfmusp.relation.referenceGorr TA, 2015, PROTEOM CLIN APPL, V9, P396, DOI 10.1002/prca.201400118eng
hcfmusp.relation.referenceGRALNICK HR, 1987, AM J HEMATOL, V24, P259, DOI 10.1002/ajh.2830240305eng
hcfmusp.relation.referenceHaberichter SL, 2008, BLOOD, V111, P4979, DOI 10.1182/blood-2007-09-110940eng
hcfmusp.relation.referenceHaberichter SL, 2006, BLOOD, V108, P3344, DOI 10.1182/blood-2006-04-015065eng
hcfmusp.relation.referenceHarlow E, 1988, ANTIBODIES LAB MANUA, P726eng
hcfmusp.relation.referenceHOYER LW, 1980, BLOOD, V55, P1056eng
hcfmusp.relation.referenceJohnstone IB, 1997, J VET DIAGN INVEST, V9, P314, DOI 10.1177/104063879700900316eng
hcfmusp.relation.referenceJust S, 2017, SEMIN THROMB HEMOST, V43, P75, DOI 10.1055/s-0036-1592164eng
hcfmusp.relation.referenceKAMIGUTI AS, 1991, TOXICON, V29, P961, DOI 10.1016/0041-0101(91)90079-7eng
hcfmusp.relation.referenceKurien BT, 2003, J IMMUNOL METHODS, V274, P1, DOI 10.1016/S0022-1759(02)00523-9eng
hcfmusp.relation.referenceLaffan M., 2011, DACIE LEWIS PRACTICA, P393eng
hcfmusp.relation.referenceLenting PJ, 2015, BLOOD, V125, P2019, DOI 10.1182/blood-2014-06-528406eng
hcfmusp.relation.referenceLopes AA, 2002, BRAZ J MED BIOL RES, V35, P1259, DOI 10.1590/S0100-879X2002001100002eng
hcfmusp.relation.referenceMARUYAMA M, 1990, THROMB HAEMOSTASIS, V63, P449eng
hcfmusp.relation.referenceMILLER JL, 1991, P NATL ACAD SCI USA, V88, P4761, DOI 10.1073/pnas.88.11.4761eng
hcfmusp.relation.referenceNg C, 2015, BLOOD, V125, P2029, DOI 10.1182/blood-2014-08-528398eng
hcfmusp.relation.referenceNichols T. C., 2010, THROMBOSIS, V2010eng
hcfmusp.relation.referenceOtt HW, 2010, AM J CLIN PATHOL, V133, P322, DOI 10.1309/AJCPZSBTD2BWOMVLeng
hcfmusp.relation.referencePasotti F, 2013, ELECTROPHORESIS, V34, P818, DOI 10.1002/elps.201200538eng
hcfmusp.relation.referencePatton WF, 2000, ELECTROPHORESIS, V21, P1123, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1123::AID-ELPS1123>3.3.CO;2-5eng
hcfmusp.relation.referencePerutelli P, 1997, HAEMATOLOGICA, V82, P510eng
hcfmusp.relation.referencePruthi RK, 2010, THROMB RES, V126, P543, DOI 10.1016/j.thromres.2010.09.015eng
hcfmusp.relation.referencePukac LA, 1997, BIOTECHNIQUES, V23, P385, DOI 10.2144/97233bm08eng
hcfmusp.relation.referenceRUGGERI ZM, 1981, BLOOD, V57, P1140eng
hcfmusp.relation.referenceRUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795eng
hcfmusp.relation.referenceSadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.xeng
hcfmusp.relation.referenceSadler J. E., 2013, HEMOSTASIS THROMBOSI, P670eng
hcfmusp.relation.referenceSANDERS WE, 1988, LAB INVEST, V59, P443eng
hcfmusp.relation.referenceSanders YV, 2015, BLOOD, V125, P3006, DOI 10.1182/blood-2014-09-603241eng
hcfmusp.relation.referenceSantoro ML, 2004, THROMB HAEMOSTASIS, V92, P369, DOI 10.1160/TH04-02-0120eng
hcfmusp.relation.referenceSchneppenheim R, 2001, BLOOD, V97, P2059, DOI 10.1182/blood.V97.7.2059eng
hcfmusp.relation.referenceSeidel H., 2017, RES PRACT THROMB SS1, V1, P717eng
hcfmusp.relation.referenceSerrano SMT, 2007, FEBS J, V274, P3611, DOI 10.1111/j.1742-4658.2007.05895.xeng
hcfmusp.relation.referenceSmejkal GB, 2003, ELECTROPHORESIS, V24, P582, DOI 10.1002/elps.200390068eng
hcfmusp.relation.referenceSpringer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638eng
hcfmusp.relation.referenceStudt JD, 2001, AM J CLIN PATHOL, V116, P567eng
hcfmusp.relation.referenceTAKAHASHI H, 1984, BLOOD, V64, P1254eng
hcfmusp.relation.referenceVincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831eng
hcfmusp.relation.referencevon Willebrand EA, 1999, HAEMOPHILIA, V5, P223eng
hcfmusp.relation.referenceWeiss DR, 2008, THROMB HAEMOSTASIS, V100, P949, DOI 10.1160/TH08-06-0403eng
hcfmusp.relation.referenceWorld Federation of Hemophilia, 2016, REP ANN GLOB SURV 20, P64eng
hcfmusp.relation.referenceYamashita KM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002814eng
hcfmusp.relation.referenceZIMMERMAN TS, 1986, J CLIN INVEST, V77, P947, DOI 10.1172/JCI112394eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublicationbbc1905d-5fd1-4e63-85f7-2005887820d8
relation.isAuthorOfPublication37a68e33-d879-4897-9d69-330f781c6585
relation.isAuthorOfPublication8f98eea9-93a5-464f-a43a-046d80146491
relation.isAuthorOfPublication313da143-42e1-47de-8616-9b5be5b4606b
relation.isAuthorOfPublicationf5b18e21-f58b-4ced-8e7e-8a2c23745396
relation.isAuthorOfPublication.latestForDiscoverybbc1905d-5fd1-4e63-85f7-2005887820d8
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_THOMAZINI_Optimization_of_von_Willebrand_factor_multimer_analysis_in_2019.PDF
Tamanho:
2.26 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)